Çağdaş Kalkan

Çağdaş Kalkan

Auto-generated profile, based on publicly available information

Çağdaş Kalkan

Department of Gastroenterology, Gazi University Faculty of Medicine, Ankara, Türkiye

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 February 2023 in Journal of Viral Hepatitis
Verified
Journal Article
Closed access
ÇKÇağdaş Kalkan
Çağdaş Kalkan
YYYusufcan Yilmaz
Yusufcan Yilmaz
BEBeyza Doğanay Erdoğan
Beyza Doğanay Erdoğan
BSBerna Savaş
Berna Savaş
EYEsra Yurdcu
Esra Yurdcu
CYCihan Yurdaydin
Cihan Yurdaydin

1 April 2015 in Journal of Hepatology
Verified
Journal Article
Closed access
CYCihan Yurdaydin
Cihan Yurdaydin
RIR. Idilman
R. Idilman
ICI. Choong
I. Choong
CKC. Kalkan
C. Kalkan
OKOnur Keskin
Onur Keskin
JGJeffrey S. Glenn
Jeffrey S. Glenn

25 November 2024 in Turkish Journal of Gastroenterology
Verified
Journal Article
Open access
ISİrFan Soykan
İrFan Soykan
RERamazan Erdem Er
Ramazan Erdem Er
YBYigit Baykara
Yigit Baykara
CKCağdaş Kalkan
Cağdaş Kalkan
Autoimmune gastritis is an immune-mediated disease characterized by the destruction of parietal cells and atrophy of the oxyntic mucosa due to anti-parietal cell antibodies. It may lead to serious conditions including iron/vitamin B12 and micronutrient deficiencies, neurological disorders, and gastric malignancies. The exact mechanism of this disease is not exactly understood; however, dysregu lated immunological mechanisms appear to be major contributors. Patients with this disease are often asymptomatic but may present with gastrointestinal symptoms and/or iron/vitamin B12 deficiencies. Although important serological markers are available and despite advanced endoscopic techniques, the definitive diagnosis relies on histopathological examination of gastric corporal biopsy specimens. Autoimmune gastritis is closely related with increased risk of gastric neuroendocrine tumors and gastric adenocarcinoma. Patients with autoimmune gastritis do not benefit from specific treatments, thus, management is directed to restore micronutrient deficiencies and to prevent occurrence of neoplastic transformation with appropriate endoscopic surveillance. Cite this article as: Soykan İ, Er RE, Baykara Y, Kalkan C. Unraveling the mysteries of autoimmune gastritis. Turk J Gastroenterol. 2025;36(3):135-144.

1 October 2022 in Turkish Journal of Gastroenterology
Verified
Journal Article
Open access
EKEmra Asfuroğlu Kalkan
Emra Asfuroğlu Kalkan
ÇKÇağdaş Kalkan
Çağdaş Kalkan
SKSabite Kaçar
Sabite Kaçar
SBSezgin Barutcu
Sezgin Barutcu
MYMahmut Yüksel
Mahmut Yüksel
ISİrFan Soykan
İrFan Soykan
Background: Acute pancreatitis is an abrupt inflammatory disease of the exocrine pancreas and it can occur in different severities. It is becoming more common and more mortal in the gerontal population. The aim of our study was to explore the similarities and differences between young and gerontal patients with acute pancreatitis, with a special emphasis on patients over 80 years of age. Methods: Medical records of patients (n = 1150) with acute pancreatitis were analyzed retrospectively. Several scoring systems including Bedside index for severity in acute pancreatitis, Ranson’s score, Harmless acute pancreatitis score, Acute Physiology and Chronic Health Evaluation, Balthazar Grade, Glasgow score, and Japanese severity score were applied at admission. Patients were divided into 3 groups; group I, young group (n = 706), if they were aged <65 years; group II, older group (n = 338), if they were aged ≥65 years to <80 years; group III, octogenarian group (n = 106), if they were aged ≥ 0 years. Results: In total, 1150 patients with acute pancreatitis were analyzed. Octogenarian group (n = 42, 39.6%) showed a more severe acute pancreatitis compared to patients in group I (n = 15, 2.1%) and II (n = 50, 14.8%, P < .001). Complications were more common in patients in group III (P < .001). Mortality rate was higher in patients in group III (n = 53, 50%) compared to group I (n = 8, 1.1%) and group II (n = 53, 15.7%) (P < .001). Conclusion: Gerontal patients with acute pancreatitis tend to have more severe disease and systemic and local complications. Mortality rates were higher in older patients compared to younger patients. Cite this article as: Asfuroğlu Kalkan E, Kalkan Ç, Kaçar S, et al. Similarities and differences between gerontal and young patients with acute pancreatitis: Evaluation of clinical characteristics and outcomes. Turk J Gastroenterol. 2022;33(10):874-884.

28 June 2022 in Journal of Hepato-Biliary-Pancreatic Sciences
Verified
Journal Article
Closed access
FAFatih Acehan
Fatih Acehan
MTMesut Tez
Mesut Tez
CKCagdas Kalkan
Cagdas Kalkan
MAMeral Akdogan
Meral Akdogan
EAEmin Altiparmak
Emin Altiparmak
IAIhsan Ates
Ihsan Ates

1 July 2022 in Turkish Journal of Gastroenterology
Verified
Journal Article
Closed access
EKEmra Asfuroğlu Kalkan
Emra Asfuroğlu Kalkan
ÇKÇağdaş Kalkan
Çağdaş Kalkan
SBSezgin Barutcu
Sezgin Barutcu
OKOrhan Kucuksahin
Orhan Kucuksahin
ÖTÖzge Güçbey Türker
Özge Güçbey Türker
ISİrFan Soykan
İrFan Soykan
Background: Many rheumatic diseases may cause gastrointestinal manifestations. The goal of this study was to analyze the prevalence and predictors of gastrointestinal involvement in patients with rheumatic disorders. Methods: A retrospective chart review was performed for patients with systemic lupus erythematosus, rheumatoid arthritis, and sys- temic sclerosis who have consulted due to gastrointestinal symptoms. The relationship between clinical symptoms, gastroscopic/colo- noscopic findings, and histopathological results with current drugs and disease duration was evaluated. Results: A total of 364 patients with rheumatic disorders and 740 people as control group were included in the study. Abdominal bloating followed by abdominal pain, regurgitation, and heartburn were reported as the main complaints by more than half of the patients. Most of the patients had gastric mucosal changes expressed as Lanza score, and the presence of major polypharmacy was the most important factor affecting Lanza score (odds ratio: 10, 95% CI: 1.882-54.111, P < .007) followed by disease duration (odds ratio: 1.559, 95% CI: 1.369-1.775, P < .001) and age (odds ratio: 1.069, 95% CI: 1.030-1.109, P < .001). In general, approximately 30% of the patients were posi- tive for Helicobacter pylori infection and 35% showed intestinal metaplasia in histopathological examination. Most of the colonoscopic findings were associated with colonic polyps (n = 81). In multivariate analysis, disease duration was the only factor that affected the pres- ence of colonic lesions (Area Under the Receiver Operating Characteristic (ROC) Curve (AUROC): 0.871, 95% CI: 0.824-0.918, P < .001). Conclusion: Patients with rheumatologic diseases frequently have gastrointestinal manifestations. The most encountered gastrointes- tinal symptom was abdominal bloating, followed by abdominal pain. Being aware of gastrointestinal manifestations and their determi- nants may help physicians manage and follow patients with rheumatologic disorders.